Abstract
The global market for spinal nonfusion technologies, comprising sales of
interspinous process decompression (IPD) devices, pedicle screw-based dynamic
stabilization (PSBDS) systems, cervical artificial discs (CADs), lumbar
artificial discs (LADs), nuclear disc prostheses (NDPs), annulus repair (AR)
devices, and facet arthroplasty (FA) devices, will expand robustly over the
forecast period. This will be attributed to the aging population because a
number of spinal pathologies, such as degenerative disc disease (DDD), are
age-related. Moreover, a greater volume of patients will pursue spinal
nonfusion over the alternative, spinal fusion, due to its motion-preserving
benefits. The market will, however, be limited by cost-containment
initiatives, particularly during the economic downturn. Governments and
hospitals are placing pressure on manufacturers to lower their prices, thus
impeding average selling price (ASP) growth. Despite this, as new nonfusion
devices are introduced and physicians and patients become more aware of their
benefits, procedure volumes will rise. The global spinal nonfusion technology
market will therefore expand at a strong compound annual growth rate (CAGR)
through 2013
|